These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2332507)

  • 41. In vivo hematological effects of seven days of rhIL-6 in neonatal rats.
    Cairo MS; Plunkett JM; Clark S; van de Ven C
    Am J Pediatr Hematol Oncol; 1992; 14(1):44-7. PubMed ID: 1550262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
    Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
    Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human interleukin-3 induces extramedullary hematopoiesis at subcutaneous injection sites in cynomolgus monkeys.
    Khan KN; Kats AA; Fouant MM; Snook SS; Mckearn JP; Alden CL; Smith PF
    Toxicol Pathol; 1996; 24(4):391-7. PubMed ID: 8864180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
    Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
    Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombopoietic activity of recombinant human interleukin 11 (rHuIL-11) in normal and myelosuppressed nonhuman primates.
    Schlerman FJ; Bree AG; Kaviani MD; Nagle SL; Donnelly LH; Mason LE; Schaub RG; Grupp SA; Goldman SJ
    Stem Cells; 1996 Sep; 14(5):517-32. PubMed ID: 8888493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interleukin-3: a preclinical study].
    Valent P; Geissler K; Bettelheim P
    Wien Klin Wochenschr; 1989 Oct; 101(19):652-63. PubMed ID: 2482586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo.
    Hintz-Obertreis P; Weinmann E; Seiler FR
    Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
    J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo administration of recombinant interleukin-2 induces granulocyte-macrophage colony formation in a murine system.
    Lafreniere R; Houwen B; Rankin C; Borkenhagen K; Phillips M
    J Biol Response Mod; 1990 Aug; 9(4):420-5. PubMed ID: 2395005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice.
    Tian ZG; Woody MA; Sun R; Welniak LA; Raziuddin A; Funakoshi S; Tsarfaty G; Longo DL; Murphy WJ
    Stem Cells; 1998; 16(3):193-9. PubMed ID: 9617894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo effects of interleukin-1 receptor antagonist on hematopoietic bone marrow progenitor cells in normal mice.
    Jovcic G; Ivanovic Z; Biljanovic-Paunovic L; Bugarski D; Stosic-Grujicic S; Milenkovic P
    Eur Cytokine Netw; 1996; 7(1):71-4. PubMed ID: 8704098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Highly increased production of bone marrow-derived blood cells by administration of homologous interleukin-3 to rhesus monkeys.
    Wagemaker G; van Gils FC; Burger H; Dorssers LC; van Leen RW; Persoon NL; Wielenga JJ; Heeney JL; Knol E
    Blood; 1990 Dec; 76(11):2235-41. PubMed ID: 2257298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promegapoietin-1a, an engineered chimeric IL-3 and Mpl-L receptor agonist, stimulates hematopoietic recovery in conventional and abbreviated schedules following radiation-induced myelosuppression in nonhuman primates.
    Farese AM; Smith WG; Giri JG; Siegel N; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(4):329-38. PubMed ID: 11463953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long-term follow-up of hematopoiesis.
    Drouet M; Mourcin F; Grenier N; Leroux V; Denis J; Mayol JF; Thullier P; Lataillade JJ; Herodin F
    Blood; 2004 Feb; 103(3):878-85. PubMed ID: 14525791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.
    Thomas JW; Baum CM; Hood WF; Klein B; Monahan JB; Paik K; Staten N; Abrams M; McKearn JP
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3779-83. PubMed ID: 7537376
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical effects of recombinant human interleukin-3.
    Ganser A; Lindemann A; Seipelt G; Ottmann OG; Herrmann F; Eder M; Frisch J; Schulz G; Mertelsmann R; Hoelzer D
    Am J Clin Oncol; 1991; 14 Suppl 1():S51-63. PubMed ID: 2048566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy.
    Rodgers K; Xiong S; DiZerega GS
    Cancer Chemother Pharmacol; 2003 Feb; 51(2):97-106. PubMed ID: 12647010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.